Aperio Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $179K | Buy |
5,118
+841
| +20% | +$29.4K | ﹤0.01% | 2323 |
|
|
2020
Q3 | $103K | Buy |
4,277
+2,408
| +129% | +$58K | ﹤0.01% | 2317 |
|
|
2020
Q2 | $34K | Sell |
1,869
-1,322
| -41% | -$24K | ﹤0.01% | 2313 |
|
|
2020
Q1 | $50K | Sell |
3,191
-427
| -12% | -$6.69K | ﹤0.01% | 2279 |
|
|
2019
Q4 | $77K | Buy |
3,618
+427
| +13% | +$9.09K | ﹤0.01% | 2283 |
|
|
2019
Q3 | $60K | Buy |
3,191
+2,567
| +411% | +$48.3K | ﹤0.01% | 2274 |
|
|
2019
Q2 | $16K | Buy |
+624
| New | +$16K | ﹤0.01% | 2723 |
|
|
2014
Q3 | – | Sell |
-2,318
| Closed | -$84K | – | 1767 |
|
|
2014
Q2 | $84K | Sell |
2,318
-75
| -3% | -$2.72K | ﹤0.01% | 1692 |
|
|
2014
Q1 | $93K | Buy |
+2,393
| New | +$93K | ﹤0.01% | 1975 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 1942 |
|